Health Risk Profile Test
Advanced specialty test to assess risk levels for common health problems
Advanced specialty test to assess the level of cellular damage caused by free radicals
Our metabolism naturally produces free radicals as a result of chemical processes. Free radicals are typically combatted by antioxidants, but can cause cellular damage when produced in excess. Oxidative stress is a condition where overwhelming free radicals damage cellular components. Free radicals are associated with aging and diseases such as cancer, Alzheimer’s disease, Parkinson’s disease, and many others.
High oxidative stress can necessitate the need for dietary adjustments, lifestyle modification, and antioxidant supplementation to help mitigate negative effects.
What we can measure: cysteine, glutathione, lipid peroxides, sulfate, total antioxidant capacity, superoxide dismutase, 8-OHdG
This advanced specialty test from BioBalance is ideal for: individuals with or at risk of chronic fatigue syndrome, environmental sensitivity, and inflammatory disorders.
Advanced specialty test to assess the level of risk for Cardiovascular Disease
Testing for lipid markers like LDL/HDL cholesterol and triglycerides are informative but insufficient when it comes to the comprehensive assessment of an individual’s risk for cardiovascular disease. This test analyzes blood for lipid markers and independent risk factors leading to cardiovascular disease. A combination of standard lipid markers and advanced biomarkers can provide information on cholesterol metabolism, inflammation, and insulin resistance. This will help clinicians develop targeted and personalized treatments to address specific metabolic areas that can help lower health risks and improve cardiovascular health.
What we can measure: LDL, HDL (with particle number & size), Total Cholesterol, Triglycerides, Lp(a), hs-CRP, PLAC, fibrinogen, hymocysteine, Insulin Resistance Score
This advanced specialty test from BioBalance is ideal for:
- Patients with family history of heart disease
- Patients experiencing premature cardiovascular disease
- Patients with abnormal serum lipids
- Patients suffering from obesity and/or diabetes
- Physically inactive individuals
Advanced specialty test to assess the rate of bone loss and risk for osteoporosis.
Some individuals are more likely to develop osteoporosis. Clinical intervention is important before significant bone loss has occurred and when monitoring the effectiveness of treatments performed. This urinary test is designed to examine the current rate of bone loss, lytic bone disease, and efficacy of bone support therapies. Presence in the urine of of bothpyridinoline (PYD) and deoxypyridinoline (DPD) can reflect a person’s current rate of bone loss.
What we can measure: pyridinium crosslinks, creatinine, deoxypyridinoline
This advanced specialty test from BioBalance is ideal for: individuals who have family history of osteoporosis, regularly consume caffeine or alcohol, and have lack of exercise or physical activity.